BIORQ — Biora Therapeutics Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual cashflow statement for Biora Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-148	-193	-247	-38.2	-124
Depreciation
Deferred Taxes
Non-Cash Items	2.91	72.9	104	-22.5	66.4
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	32.7	-51.2	-25.9	-4.65	8.62
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Cash from Operating Activities	-106	-166	-167	-64.4	-48.5
Capital Expenditures	-3.73	-4.94	-0.855	-0.792	-0.103
Purchase of Fixed Assets
Other Investing Cash Flow Items	20.3	0	-0.387	0	2.55
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	16.5	-4.94	-1.24	-0.792	2.44
Financing Cash Flow Items	-4.68	-6.75	-5.53	-5.12	-5.36
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	73.6	230	165	7.3	30.8
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-16	59	-3.68	-57.9	-15.3